Osteogenicpeptides Osteogenic Growth Peptide (OGP) is a naturally occurring, 14-amino acid peptide found in the blood serum of mammals at micromolar concentrations.2022年5月23日—In adult mice, exogenous administration of OGP completely prevented age-related bone loss. Our findings suggest that OGP attenuates age-related ... This endogenous peptide plays a crucial role in the body's systemic osteogenic response, meaning it is vital for bone formation, regeneration, and overall bone homeostasis. Research indicates that OGP has the potential to stimulate bone tissue regeneration, making it a significant focus in studies related to bone health and therapeutic development.
OGP is derived from the C-terminal region of histone H4, a protein integral to DNA packaging within cells. The active peptide sequence is typically referred to as OGP(1-14) or simply OGP, with the specific sequence ALKRQGRTLYGFGG being commonly cited. Further research has identified that a C-terminal pentapeptide fragment, OGP(10-14) (YGFGG), retains significant OGP-like bioactivities. This suggests that the latter part of the peptide sequence is particularly important for its biological functions.
The primary function of osteogenic growth peptide lies in its ability to promote osteogenesis, the process by which bone tissue is formed. Studies have demonstrated that OGP can stimulate the proliferation and differentiation of osteoblastic cells, the cells responsible for building new bone. It also influences alkaline phosphatase activity, an enzyme critical for bone mineralization.May be the osteoinductive factor responsible for the phenomenon of epithelial osteogenesis. Plays a role in calcium regulation and bone homeostasis. Homodimer; ... Beyond its direct role in bone formation, OGP has been shown to:
* Enhance Bone Formation and Density: In animal models, administration of OGP has led to increased bone formation and improved trabecular bone density, suggesting its potential in treating conditions characterized by bone loss.
* Stimulate Fracture Healing: OGP has been observed to accelerate fracture healing processes, highlighting its therapeutic promise for bone injuries.
* Exhibit Anti-inflammatory Properties: Emerging research suggests OGP possesses potent anti-inflammatory effects, which may indirectly contribute to bone health by mitigating inflammatory processes that can lead to bone loss, particularly age-related bone lossSequentially Releasing Aspirin and Osteogenic Growth ....
* Influence Hematopoiesis: OGP is also implicated in hematopoiesis, the formation of blood cellular components, indicating a broader role in tissue regeneration.
* Regulate Calcium Homeostasis: The peptide may play a role in calcium regulation and maintaining overall bone homeostasis.
The scientific community has extensively investigated osteogenic growth peptide for its therapeutic applicationsThe Role of Peptides in Wellness and Orthopedic Care - Dr Nicholas Frisch. While much of the current research is preclinical, the findings are promising. Studies have explored OGP in various contexts, including:
* Drug Design: The understanding of OGP's structure and function has paved the way for drug design strategies aimed at leveraging its osteogenic propertiesOsteogenic Growth Peptide (10-14) is responsible for the binding to the OGP receptor and activates an intracellular Gi-protein-MAP kinase signaling pathway..
* Regenerative Medicine: OGP is being explored as a component in scaffolds and delivery systems designed to promote bone regeneration after injury or disease.Osteogenic growth peptide: from concept to drug design For instance, engineered scaffolds that sequentially release OGP along with other therapeutic agents like aspirin are being developed to enhance healing and reduce inflammation.Sequentially Releasing Aspirin and Osteogenic Growth ...
* Treating Bone Disorders: Its ability to stimulate bone formation and density makes OGP a potential candidate for treating conditions such as osteoporosis and other forms of bone fragility.
* Research Use: Currently, OGP is primarily available for research purposes, often indicated as "NOT FOR HUMAN OR ANIMAL CONSUMPTION" or "FOR RESEARCH USE ONLY1996年12月15日—The osteogenic growth peptide (OGP)was characterized recently in regenerating bone marrow (BM) and normal serum.." This underscores that while its potential is recognized, it is not yet approved for clinical use.
Despite its promising attributes, the clinical application of osteogenic growth peptide faces certain challenges. One significant hurdle is its short half-life and potential for abrupt release, which can limit its therapeutic efficacy. Researchers are actively working on developing sustained-release formulations and delivery systems to overcome these limitations. Furthermore, ongoing research aims to fully elucidate the signaling pathways activated by OGP, including its interaction with specific receptors like the OGP receptor and its involvement in Gi-protein-MAP kinase signaling.
Osteogenic Growth Peptide (OGP) stands out as a significant endogenous peptide with profound implications for bone health and regeneration. Its demonstrated ability to stimulate osteoblast activity, enhance bone formation, and potentially reduce inflammation positions it as a molecule of considerable interest for future therapeutic interventions in bone-related diseases and injuries.Sequentially Releasing Aspirin and Osteogenic Growth ... As research progresses, the development of effective delivery methods and a deeper understanding of its complex biological roles will be key to unlocking the full clinical potential of OGP.Osteogenic Growth Peptide, OGP acetate - PubChem
Join the newsletter to receive news, updates, new products and freebies in your inbox.